Inactive Instrument

Press Releases Prometheus Biosciences, Inc.

Equities

RXDX

US74349U1088

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Merck Completes Acquisition of Prometheus Biosciences, Inc.	23-06-19	AQ
PROMETHEUS BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	23-06-15	AQ
RXDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Prometheus Biosciences, Inc. Is Fair to Shareholders	23-05-24	BU
PROMETHEUS BIOSCIENCES, INC. : Other Events (form 8-K)	23-05-23	AQ
PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX	23-05-22	BU
PROMETHEUS BIOSCIENCES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-09	AQ
Prometheus Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Progress	23-05-09	AQ
PROMETHEUS BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX	23-04-21	BU
BioStock: Major acquisition to strengthen Merck's immunology pipeline	23-04-20	AQ
Peabody Energy, Prometheus rise; State Street, Roblox fall	23-04-17	AQ
Merck to develop mAb through $10.8b acquisition	23-04-17	AQ
Prometheus Biosciences' : comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology - Form 8-K	23-04-17	PU
PROMETHEUS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-17	AQ
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.	23-04-16	AQ
PROMETHEUS BIOSCIENCES, INC. : Regulation FD Disclosure (form 8-K)	23-03-10	AQ
Prometheus Biosciences to Present at the Oppenheimer 33rd Annual Healthcare Conference	23-03-09	AQ
PROMETHEUS BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-02-28	AQ
Prometheus Biosciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Progress	23-02-28	AQ
Prometheus Biosciences Announces Two Oral Presentations on PRA023 at the 18th Congress of European Crohn's and Colitis Organisation	23-02-23	AQ
Prometheus Biosciences Announces Two Oral Presentations on PRA023 at the 18th Congress of European Crohn’s and Colitis Organisation (ECCO)	23-02-22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Prometheus Biosciences, Inc.

Equities

RXDX

US74349U1088

Press Releases

Filters